Lingue di lavoro:
Da Italiano a Inglese
Client-vendor relationship recorded successfully! Katy Bryce has been added to your list of hired vendors.
Rate vendor Manage list Katy Bryce IT>EN Life Sciences, Medical Specialist Regno Unito
Ora locale : 03:35 BST (GMT+1)
Madrelingua : Inglese (Variants: UK, US)
Feedback from clients and colleagues on Willingness to Work Again 1 positive review
What Katy Bryce is working on Traduttore e/o interprete freelance This person has a SecurePRO™ card. Because this person is not a ProZ.com Plus subscriber, to view his or her SecurePRO™ card you must be a ProZ.com Business member or Plus subscriber .
This person is not affiliated with any business or Blue Board record at ProZ.com.
Translation, MT post-editing, Editing/proofreading, Subtitling Specializzazione: Medicina: Farmaceutica Medicina: Sistema sanitario Medicina (generale) Biologia (Biotecnologia, Biochimica, Microbiologia) Medicina: Cardiologia Medico: Odontoiatria Medicina: Strumentazione Nutrizione Psicologia Sicurezza
Altre aree di lavoro: Scienza (generale) Genetica
More
Less
Punti PRO: 36 , Risposte a domande: 14 , Domande inviate: 2 Master's degree - University of Essex Anni di esperienza: 7 Registrato in ProZ.com: Apr 2021. N/A Da Italiano a Inglese (University of Essex, verified) CIOL Adobe Acrobat, Adobe Photoshop, Microsoft Excel, Microsoft Office Pro, Microsoft Word, Powerpoint, Trados Studio, Wordfast Katy Bryce sottoscrive ProZ.com's Linee guida professionali .
Biografia
More than five million words handled in the life sciences and medical fields, including the
following types of documentation:
Ethics Committee Correspondence, Regulatory Authority Correspondence, Informed Consent
Forms, Information Sheets, Clinical Trial Agreements, SAE Reports, Discharge Letters,
Handwritten Medical Records Clinical Diary Notes, Medical Journal Articles, Death
Certificates, Medical Imaging Reports, Lab Tests, CVs
Parole chiave: italian, english, clinical trial, life sciences, adverse events, patient safety, ethics committee, regulatory authority, informed consent, clinical trial agreement
Ultimo aggiornamento del profilo Sep 6, 2023